Frequently Asked Questions

No. In this study of 459 depressed patients, the authors concluded that the results did not support lowering the DSM-5-TR diagnostic threshold for mixed features from 3 criteria to 2. Patients with exactly 2 mixed features did not show the broader pattern of validators expected for mixed depression, even though lowering the threshold substantially increased the number of patients classified as having mixed features.

Lowering the cutoff from 3 symptoms to 2 increased prevalence markedly. Using the DSM-5-TR majority-of-episode time frame, prevalence rose from 3.9% (n=18) to 13.1% (n=60). Using a past-week time frame, prevalence increased from 9.4% (n=43) to 22.9% (n=105).

No. When the analysis was limited to patients with exactly 2 mixed features and excluded those with 3 or more features, the difference between bipolar disorder and major depressive disorder was not significant: 19.1% versus 15.5%, with an odds ratio of 1.29 (95% CI, 0.592.79). By contrast, bipolar disorder was significantly more likely than major depressive disorder to meet the standard 3-symptom threshold.

The standard 3-symptom threshold showed stronger diagnostic discrimination. Patients with bipolar disorder were significantly more likely than patients with major depressive disorder to meet the mixed features specifier at 3 or more symptoms: 29.8% versus 9.2%, with an odds ratio of 4.18 (95% CI, 2.068.48). This finding supported the validity of the current threshold better than a 2-symptom cutoff.

No. In patients with major depressive disorder, those with exactly 2 mixed features did not differ from patients with 0 or 1 feature in functioning, age at onset, psychiatric hospitalization history, family history of bipolar disorder, comorbid disorders, or lifetime suicide attempts. Compared with patients who had 3 or more mixed features, the 2-feature group had significantly lower rates of social anxiety disorder, borderline personality disorder, and attention deficit disorder, and they were significantly less likely to have attempted suicide.

The main difference was greater current symptom severity rather than stronger bipolar-linked validators. Compared with patients without mixed features, patients with exactly 2 mixed features had greater symptom severity, although the difference on the Hamilton Depression Rating Scale was not significant. They did not differ from patients without mixed features in suicidal ideation during the week before evaluation, functioning, age of onset, psychiatric hospitalization, family history of bipolar disorder, or lifetime suicide attempts.

Yes. The assessment window changed prevalence substantially. Only 3.9% of the full sample met DSM-5-TR mixed-features criteria for the majority of the depressive episode, whereas 9.4% met criteria during the week before assessment. The study therefore shows that symptom timing can materially affect how often mixed features are identified.

The investigators studied 459 patients with current major depressive disorder or bipolar disorder in a depressive episode who presented for intake evaluation at a Rhode Island partial hospital program. They compared 3 groups: patients with 01 DSM-5-TR mixed features, exactly 2 mixed features, and 3 or more mixed features. Their test of validity was whether the 2-feature group resembled the 3-or-more-feature group and differed from the 01-feature group on variables previously linked to mixed depression, including bipolar diagnosis, family history of bipolar disorder, age of onset, depressive episodes, suicidality, severity, comorbidity, and functioning.

The authors noted several limitations. The study was conducted in a single clinical program, and most patients were white, female, and insured, which may limit generalizability. The same interviewer completed the mixed-features interview and the clinician rating scales, the sample of patients with major depressive disorder who met full DSM-5-TR mixed-features criteria was relatively small, and replication in other clinical and community samples was recommended.